Alternative (non-animal) methods for cosmetic testing: current status and future prospects – Acute toxicity

Alternatives to Laboratory Animals, 33 (S1) Chapter 3.1, Acute Toxicity: 27-34

GRIBALDO L., GENNARI A., BLACKBURN K., CLEMEDSON C., DEGUERCY A., MENEGUZ A., PFALLER W. and RUHDEL I. (2005)

ECVAM, Institute for Health & Consumer Protection, European Commission Joint Research Centre, Ispra, (VA), Italy.
Procter & Gamble, Miami Valley Laboratories, Ross, OH, USA.
Expertrådet, Sundbyberg, Sweden.
Laboratory of Pharmacology, Istituto Superiore di Sanita’, Roma, Italy.
Bioalternatives, Gençay, France.
University of Innsbruck, Innsbruck, Austria.
German Animal Welfare Federation, Neubiberg, Germany.

Abstract

From the regulatory point of view, the main objective of acute toxicity testing is basically to classify chemicals according to their intrinsic toxicity as required by the EEC directive on the classification, packaging, and labelling of dangerous substances (Council Directive 67/548/EEC and subsequent amendments). This requirement aims to protect public health by regulating exposure to potentially dangerous materials.
The classification of chemicals is done on the basis of the medium lethal dose (LD50) value, defined as « the statistically derived single dose of a substance that can be expected to cause death in 50% of the animals in an experimental group ».

© 2005 L. Gribaldo et al.

KEYWORDS: Acute toxicity; Cosmetic testing; Alternative methods

Related posts

Check out Bioalternatives’ updates and experience new testing ideas

  • Bioassays, models and services
  • Posts and publications
  • Events

  • The legal basis for the processing is consent. Your e-mail address will only be communicated to the following recipients: the departments concerned and authorised by QIMA LIFE SCIENCE. This data is kept for as long as you are registered to the newsletter.

    You can access your data, rectify it, request its deletion or exercise your right to limit the processing of your data, withdraw your consent to the processing of your data at any time, oppose the processing of your data and you have a right to the portability of your data.

    Visit cnil.fr for more information on your rights.
    You can exercise all your rights using the following linkGestion des droits or by writing to dpo-qima@agencergpd.eu. If you feel, after contacting us, that your "Informatique et Libertés" rights are not being respected, you can submit a complaint to the CNIL.

  • The information collected on this form is recorded in a file used by QIMA Life Sciences to send you its newsletter.